Feedback regulation of cholesterol uptake by the LXR-IDOL-LDLR axis
about
From evolution to revolution: miRNAs as pharmacological targets for modulating cholesterol efflux and reverse cholesterol transportLiver X receptors at the intersection of lipid metabolism and atherogenesisObesity, cholesterol metabolism, and breast cancer pathogenesisAnti-hyperlipidemic effects and potential mechanisms of action of the caffeoylquinic acid-rich Pandanus tectorius fruit extract in hamsters fed a high fat-diet.Cholesterol and breast cancer pathophysiology.Pathways of cholesterol homeostasis in mouse retina responsive to dietary and pharmacologic treatments.A Western-fed diet increases plasma HDL and LDL-cholesterol levels in apoD-/- mice.The estrogen receptor as a mediator of the pathological actions of cholesterol in breast cancer.Hepatic TRAP80 selectively regulates lipogenic activity of liver X receptor.IDOL N342S Variant, Atherosclerosis Progression and Cardiovascular Disorders in the Italian General Population.Stable liver-specific expression of human IDOL in humanized mice raises plasma cholesterol.Quantitative fluorescence imaging reveals point of release for lipoproteins during LDLR-dependent uptake.Ethanol extract of Zhongtian hawthorn lowers serum cholesterol in mice by inhibiting transcription of 3-hydroxy-3-methylglutaryl-CoA reductase via nuclear factor-kappa B signal pathway.Combined Effects of Rosuvastatin and Exercise on Gene Expression of Key Molecules Involved in Cholesterol Metabolism in Ovariectomized RatsLXR Regulation of Brain Cholesterol: From Development to Disease.Chronic Moderate Alcohol Intakes Accelerate SR-B1 Mediated Reverse Cholesterol Transport.Maternal Betaine Supplementation throughout Gestation and Lactation Modifies Hepatic Cholesterol Metabolic Genes in Weaning Piglets via AMPK/LXR-Mediated Pathway and Histone Modification.Activation of liver X receptor decreases atherosclerosis in Ldlr⁻/⁻ mice in the absence of ATP-binding cassette transporters A1 and G1 in myeloid cellsTargeting liver X receptors in inflammation.Genetics of familial hypercholesterolemia.LXR agonist treatment of blastic plasmacytoid dendritic cell neoplasm restores cholesterol efflux and triggers apoptosis.The Contribution of Cholesterol and Its Metabolites to the Pathophysiology of Breast CancerDisorders of lipid metabolism in nephrotic syndrome: mechanisms and consequences.Cholesterol uptake and regulation in high-grade and lethal prostate cancers.Shunts, channels and lipoprotein endosomal traffic: a new model of cholesterol homeostasis in the hepatocyte.AAV vectors expressing LDLR gain-of-function variants demonstrate increased efficacy in mouse models of familial hypercholesterolemia.Proteostatic Tactics in the Strategy of Sterol Regulation.Role of PCSK9 and IDOL in the pathogenesis of acquired LDL receptor deficiency and hypercholesterolemia in nephrotic syndrome.Prenatal betaine exposure modulates hypothalamic expression of cholesterol metabolic genes in cockerels through modifications of DNA methylation.Elucidating mechanistic insights into drug action for atopic dermatitis: a systems biology approach.MYLIP dimer ubiquitinates VLDLR on Lys-839
P2860
Q26997647-CA610CBC-A2E0-426D-8B31-580134DC59EEQ28082452-B7F970B7-A85E-4894-BAED-F7D154C321CCQ34204836-92DE521B-69B7-480C-A785-A7611612DE28Q34685423-A91ED7A5-322F-4698-96D5-1F39DE579CDAQ34715261-0303033B-A19A-49EA-9923-3C22EA0F71A1Q34757496-FB5E3A83-CDC2-4089-AA67-B97101A45CA5Q34790239-26A9D8DB-3F91-41E9-8920-4A1697E1751BQ35095008-2A952290-7311-4F18-8C71-D815B31B735CQ35242621-A33CEB49-1C09-4028-B70C-773A2DE25825Q35557701-6084044D-36BC-4AB7-BBE6-9378EC238682Q36702427-7980D7EF-8F35-465A-A5D4-9D69D226CEA2Q36744120-70143458-1245-47E5-A2D8-51D35CE2114CQ37107089-D01B6B9B-FEEC-4B63-9533-8BADC75D9761Q37115391-C4866A53-9DC2-47C1-91E5-A7159058BE0FQ37179244-512B39AD-B815-47DA-B72D-14981DC3854AQ37251351-15D81506-037C-4F63-8C4B-A316B0EF2D5CQ37373976-F90CE261-AC16-4CD4-940D-D454F05654E3Q37615062-AB33A706-7EDB-4226-BE9E-6A3EB89A20AEQ38112165-F0A479E1-2A1B-4226-8226-34842B7FE293Q38364881-B4D2B554-7D99-4E80-9C5B-DFB63768BC8DQ38739920-34384EAA-0539-4C5F-91F4-B2339E96148FQ38791223-4D3DFD5D-C264-4AE3-A5A6-2A979C3521CFQ38831462-1163549D-9A79-4897-9555-A3EE6AEBD617Q40167193-9C65C949-E7FB-4FEA-A9D2-C36093723D9EQ41851007-E58BF475-5F16-4B6D-9848-D21000FB87DBQ42206263-81CC56BD-AC6D-44BB-B383-5BA48681A232Q46290614-D95E57B2-F068-4795-99BE-44926313AE8BQ46578827-7D3FB05A-0F7D-476C-80C1-346DD8CDC25DQ48396575-C1D73BCC-08C4-4FB5-912E-CCB401A50FECQ49841445-3482CC75-3B81-4FA1-9E98-67105A5E9022Q50299808-339C4DF6-F8B2-4F66-A9A6-7B0355E6E2D5
P2860
Feedback regulation of cholesterol uptake by the LXR-IDOL-LDLR axis
description
2012 nî lūn-bûn
@nan
2012 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Feedback regulation of cholesterol uptake by the LXR-IDOL-LDLR axis
@ast
Feedback regulation of cholesterol uptake by the LXR-IDOL-LDLR axis
@en
Feedback regulation of cholesterol uptake by the LXR-IDOL-LDLR axis
@nl
type
label
Feedback regulation of cholesterol uptake by the LXR-IDOL-LDLR axis
@ast
Feedback regulation of cholesterol uptake by the LXR-IDOL-LDLR axis
@en
Feedback regulation of cholesterol uptake by the LXR-IDOL-LDLR axis
@nl
prefLabel
Feedback regulation of cholesterol uptake by the LXR-IDOL-LDLR axis
@ast
Feedback regulation of cholesterol uptake by the LXR-IDOL-LDLR axis
@en
Feedback regulation of cholesterol uptake by the LXR-IDOL-LDLR axis
@nl
P2093
P2860
P3181
P1476
Feedback regulation of cholesterol uptake by the LXR-IDOL-LDLR axis
@en
P2093
P2860
P304
P3181
P356
10.1161/ATVBAHA.112.250571
P407
P577
2012-11-01T00:00:00Z